April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
RPE Cytotoxicity and Caspase Activation after Treatment with Valproic Acid
Author Affiliations & Notes
  • Andre Berner
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Kablian Mohan
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Ding-Yuan Lou
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Jennifer Brown
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Justin West
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Rei Kono
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Ilene K Sugino
    Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ
  • Marco A Zarbin
    Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ
  • Jayakrishna Ambati
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Mark Ellsworth Kleinman
    Ophthalmology and Visual Sciences, University of Kentucky,College of Medicine, Lexington, KY
  • Footnotes
    Commercial Relationships Andre Berner, None; Kablian Mohan, None; Ding-Yuan Lou, None; Jennifer Brown, None; Justin West, None; Rei Kono, None; Ilene Sugino, None; Marco Zarbin, None; Jayakrishna Ambati, None; Mark Kleinman, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5991. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andre Berner, Kablian Mohan, Ding-Yuan Lou, Jennifer Brown, Justin West, Rei Kono, Ilene K Sugino, Marco A Zarbin, Jayakrishna Ambati, Mark Ellsworth Kleinman; RPE Cytotoxicity and Caspase Activation after Treatment with Valproic Acid. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5991. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Age-related macular degeneration (AMD) is a progressive disease of the retina, retinal pigment epithelium (RPE) and choroid. Recent studies suggest that the HDAC inhibitor valproic acid (VPA) has neuroprotective properties and potential therapeutic efficacy in retinal degeneration. Here, we show that intravitreous delivery of VPA in a mouse model and treatment of human cell cultures induces RPE cytotoxicity. HDACs have become a novel target in aging and neurodegenerative diseases including AMD. An improved understanding of their regulation and pharmacologic inhibition in the eye is essential prior to translation to clinical studies.

Methods: Primary human RPE (hRPE) isolates (n=6, individual single donors) were treated with VPA (1mM/4mM) or vehicle (PBS). Cell viability assays (SYTOX®, Invitrogen), caspase-3 fluorometric quantification (DEVD-AFC, Biovision) and targeted PCR arrays (Taqman®, Life) were performed. Wild-type C57BL/6J mice (n=6-8) were evaluated by fundus photography at baseline and 7 days after intravitreous injection of VPA (1/10μg). RPE/choroid flatmounts (n=4-6) were immuno-stained for the intercellular junction marker, zonula occludens-1 (ZO-1) and examined by fluorescent microscopy. RPE/choroid tissue (n=3) was harvested at 48 hours and analyzed by targeted PCR arrays.

Results: Exposure of primary hRPE isolates to the HDAC inhibitor VPA led to a two fold increase in cell death (48 hours) and to a 4 fold upregulation of caspase 3 (P<0.05) at 12 hours compared to vehicle. Intravitreous injection of VPA induced frank RPE loss, deep hypo-pigmented lesions in the fundus image and severe disruption of ZO-1 staining on RPE flatmounts. Targeted PCR arrays revealed wide-spread disruption in pro-inflammatory cytokine gene expression in both human and mouse samples.

Conclusions: Intravitreous injection in C57BL/6J mice or treatment of primary hRPE isolates with VPA induced cytotoxicity in a dose-dependent fashion with increased caspase-3 activation. Widely altered cytokine expression was observed with VPA and current studies in our laboratory have focused on the specific HDACs that are contributory to the inflammatory response.

Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 615 neuroprotection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×